Page last updated: 2024-12-07

3,3'-dipropyl-2,2'-thiadicarbocyanine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

3,3'-dipropyl-2,2'-thiadicarbocyanine: potent inhibitor of endogenous respiration of Ehrlich ascites tumor cells; RN given refers to iodide; RN for parent cpd not in Chemline 10/24/83; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID5486556
MeSH IDM0060324

Synonyms (8)

Synonym
dptdci
3-propyl-2-(5-(3-propyl-2(3h)-benzothiazolylidene)-1,3-pentadienyl)benzothiazolium iodide
3,3'-dipropyl-2,2'-thiadicarbocyanine
benzothiazolium, 3-propyl-2-(5-(3-propyl-2(3h)-benzothiazolylidene)-1,3-pentadienyl)-, iodide
3,3'-dipropylthiodicarbocyanine iodide
dis c3-(5)
disc3(5)
3-propyl-2-[(2e,4e)-5-(3-propyl-1,3-benzothiazol-3-ium-2-yl)penta-2,4-dienylidene]-1,3-benzothiazole;iodide
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (130)

TimeframeStudies, This Drug (%)All Drugs %
pre-199073 (56.15)18.7374
1990's28 (21.54)18.2507
2000's16 (12.31)29.6817
2010's11 (8.46)24.3611
2020's2 (1.54)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other134 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]